@article{a19dec2d65394bb3af65e74b1f984fb4,
title = "NICE guidance on panobinostat for patients with multiple myeloma after at least two previous treatments",
keywords = "Adult, Antineoplastic Combined Chemotherapy Protocols, Bortezomib, Dexamethasone, Disease-Free Survival, Female, Humans, Hydroxamic Acids, Indoles, Male, Middle Aged, Multiple Myeloma, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Neoplasm Staging, Practice Guidelines as Topic, Prognosis, Randomized Controlled Trials as Topic, Retreatment, Risk Assessment, Survival Analysis, Treatment Outcome, United Kingdom, News",
author = "Hall, {Caroline J} and Sally Doss and Nicola Hay and Frances Sutcliffe and Andrew Stevens",
year = "2016",
month = mar,
doi = "10.1016/S1470-2045(16)00061-9",
language = "English",
volume = "17",
pages = "279--80",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Elsevier",
number = "3",
}